- Home
- NRXP vs CENN Comparison
NRXP vs CENN Comparison
Compare NRXP & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- CENN
- Stock Information
- Founded
- NRXP 2015
- CENN 2013
- Country
- NRXP United States
- CENN United States
- Employees
- NRXP N/A
- CENN N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- CENN Auto Manufacturing
- Sector
- NRXP Health Care
- CENN Consumer Discretionary
- Exchange
- NRXP Nasdaq
- CENN Nasdaq
- Market Cap
- NRXP 32.6M
- CENN 30.4M
- IPO Year
- NRXP N/A
- CENN N/A
- Fundamental
- Price
- NRXP $3.34
- CENN $0.68
- Analyst Decision
- NRXP Strong Buy
- CENN
- Analyst Count
- NRXP 4
- CENN 0
- Target Price
- NRXP $28.50
- CENN N/A
- AVG Volume (30 Days)
- NRXP 240.0K
- CENN 503.3K
- Earning Date
- NRXP 08-13-2025
- CENN 08-12-2025
- Dividend Yield
- NRXP N/A
- CENN N/A
- EPS Growth
- NRXP N/A
- CENN N/A
- EPS
- NRXP N/A
- CENN N/A
- Revenue
- NRXP N/A
- CENN $31,097,533.00
- Revenue This Year
- NRXP N/A
- CENN N/A
- Revenue Next Year
- NRXP N/A
- CENN N/A
- P/E Ratio
- NRXP N/A
- CENN N/A
- Revenue Growth
- NRXP N/A
- CENN 234.45
- 52 Week Low
- NRXP $1.10
- CENN $0.61
- 52 Week High
- NRXP $6.01
- CENN $1.84
- Technical
- Relative Strength Index (RSI)
- NRXP 60.08
- CENN 40.89
- Support Level
- NRXP $2.90
- CENN $0.61
- Resistance Level
- NRXP $3.53
- CENN $0.76
- Average True Range (ATR)
- NRXP 0.19
- CENN 0.09
- MACD
- NRXP -0.03
- CENN -0.02
- Stochastic Oscillator
- NRXP 84.13
- CENN 15.60
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About CENN Cenntro Electric Group Limited
Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.